Referred to the House Health Care & Wellness Committee on January 12, 2021
Substitute offered in the House on February 3, 2021
Authorizes the Department of Health (DOH) to approve more than one drug take-back program. Establishes requirements for program operator collaboration and allows the DOH to identify specific requirements for program promotion and consistent reporting in rule.
Referred to the House Appropriations Committee on February 5, 2021
Substitute offered in the House on March 8, 2021
The Appropriations Committee recommended the following:
• increasing the program proposal fee from $30,000 to $157,000 for proposals received
before January 1, 2024;
• specifying requirements for managing requests for prepaid mailing envelopes;
• adding clarifying language regarding the submission of program proposals from new
entities seeking to become a program operator after July 1, 2019; and
• making technical and terminology changes.